For Immediate Release

February 1, 2013

Sumitomo Chemical Reports
Consolidated Financial Results
For the Nine Months Ended December 31, 2012
The Sumitomo Chemical Group’s sales for the nine months ended December 31, 2012,were ¥1,422.3 billion, a decrease of ¥21.6 billion compared with the same period of
the previous fiscal year. Operating income was ¥36.8 billion and ordinary income was¥37.6 billion, both representing year-on-year decreases. The Group posted a net lossof ¥40.7 billion, as an additional amount was recorded as a corporate tax adjustment
due to a reversal of deferred tax assets.
The Sumitomo Chemical Group’s financial results by business segment for thenine-month period were as follows.
Basic Chemicals
Market prices fell for raw materials for synthetic fibers, and shipments of theseproducts also decreased. Sales of methyl methacrylate and aluminum declined due tolower market prices. As a result, the segment’s sales decreased by ¥22.0 billion fromthe same period of the previous fiscal year, to ¥193.7 billion, and operating income
declined by ¥15.6 billion, to a loss of ¥4.8 billion.
Petrochemicals & Plastics
Shipments from a sales subsidiary increased from the previous fiscal year’s level,
which was low due to periodic maintenance shutdowns at the manufacturing plantsof Petro Rabigh in Saudi Arabia. Sales of petrochemical products and synthetic
resins decreased in Singapore and Japan due to lower market prices overseas and a
decline in demand at home and abroad. As a result, the segment’s sales rose by ¥13.9
billion compared with the same period of the previous fiscal year, to ¥505.5 billion,
but operating income decreased by ¥7.9 billion, to a loss of ¥1.7 billion.
IT-related Chemicals
Shipments of polarizing film used in liquid crystal displays (LCDs) rose, but
shipments of color filters declined. Sales prices of both polarizing film and color
filters fell. Meanwhile, a newly-built touchscreen panel facility in South Korea began
full-fledged operation in this 3rd quarter. As a result, the segment’s sales increasedby ¥0.2 billion compared with the same period of the previous fiscal year, to ¥221.3billion, and operating income declined by ¥4.1 billion, to ¥7.2 billion.
Health & Crop Sciences
In the area of crop protection chemicals, shipments of herbicides remained strong inoverseas markets, but sales declined due to seasonal effects caused by a change inan overseas subsidiary’s fiscal year to the end of March from the end of December.
Shipments of pharmaceutical chemicals and the long-lasting insecticidal mosquito
net, Olyset® Net, decreased due to lower demand. Market prices of the feed additive
methionine declined. As a result, the segment’s sales decreased by ¥20.6 billion
compared with the same period of the previous fiscal year, to ¥170.2 billion, andoperating income declined by ¥8.6 billion, to ¥8.9 billion.

Pharmaceuticals
In Japan, shipment of Metgluco® (biguanide oral hypoglycemic) increased greatly
and shipments of Avapro® (therapeutic agent for hypertension), Lonasen® (atypicalantipsychotic) and Trerief® (therapeutic agent for Parkinson’s disease) rose. But
overall sales declined because of the significant impact of Japanese National Health
Insurance drug price revisions. In North America, shipments of Xopenex®
(short-acting beta-agonist) decreased as its exclusivity expired, but overall sales rose
thanks to gradually increasing sales of Latuda® (atypical antipsychotic) and a receiptof milestone payments of licensing fees. As a result, the segment’s sales increasedby ¥4.6 billion compared with the same period of the previous fiscal year, to ¥292.4billion, and operating income rose by ¥14.0 billion, to ¥37.3 billion.
OthersIn addition to the above five segments, the Sumitomo Chemical Group engages insupplying electrical power and steam, providing services for the design, engineering,and construction management of chemical plants, providing transport andwarehousing, and conducting materials and environmental analysis. The segment’ssales increased by ¥2.2 billion compared with the same period of the previous fiscal
year, to ¥39.2 billion, and operating income rose by ¥1.0 billion, to ¥5.8 billion.
The Company has revised its consolidated financial forecast for fiscal 2012,previously announced on October 31, 2012. The forecast has been revised downward
to sales of ¥1,970.0 billion, operating income of ¥50.0 billion, ordinary income of ¥45.0billion, and a net loss of ¥50.0 billion.
The Company regrets that it will not pay a year-end dividend as it is expected to posta large net loss for the full year. As a result, the Company’s annual dividend will be ¥6
per share for the current fiscal year.
For further details, please refer to today’s release titled “Sumitomo ChemicalAnnounces Revisions to its Financial Forecast and Projected Dividend for Fiscal 2012
and an Extraordinary Loss and Reversal of Deferred Tax Assets.”

Summary of Consolidated Results(1) Results of Operations:

Net sales
Operating income
Ordinary income
Income before income taxes
and minority interests
Net loss

Net loss per 1,000 shares

Comprehensive income(2) Financial Position:
Total assets
Total net asset(3) Cash Flows:

Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash equivalents at end of period(4) Results of Operations by
Business Segment:
Net sales
Basic Chemicals
Petrochemicals & Plastics
IT-related Chemicals
Health & Crop Sciences
Pharmaceuticals
OthersOperating income (loss)
Basic Chemicals
Petrochemicals & Plastics
IT-related Chemicals
Health & Crop Sciences
Pharmaceuticals
OthersAdjustments

9 Months ended
December 31，2012
Yen （Millions）
USD (Thousands)*
1,422,311
16,427,708
36,786424,879
37,597434,246

9 Months ended
December 31, 2011
Yen （Millions）
1,443,924
58,34948,47829,680(40,693)

342,804(470,005)

16,940(11,337)

Yen(24,894)

USD*(288)

Yen(6,936)

Yen （Millions）(27,675)

USD (Thousands)*(319,647)

Yen （Millions）(40,193)

As of December 31，2012
Yen （Millions）
USD (Thousands)*
2,357,737
27,231,890
672,6817,769,473

As of March 31, 2012
Yen （Millions）
2,336,953
720,901

9 Months ended
December 31，2012
Yen （Millions）
USD (Thousands)*
70,043808,997(138,096)(1,595,010)
42,785494,167
122,519
1,415,096

9 Months ended
December 31, 2011
Yen （Millions）
102,419(95,626)(2,478)151,373

9 Months ended
December 31，2012
Yen （Millions）
USD (Thousands)*

9 Months ended
December 31, 2011
Yen （Millions）

193,674
505,510221,286
170,248
292,431
39,162
1,422,311

2,236,937
5,838,646
2,555,856
1,966,366
3,377,581
452,322
16,427,708

215,641
491,576
221,061
190,819
287,827
37,0001,443,924(4,756)(1,659)7,227
8,912
37,2505,774(15,962)
36,786(54,932)(19,161)
83,472102,934
430,238
66,690(184,361)
424,879

10,873
6,284
11,332
17,47923,243
4,807(15,669)
58,349(Note)*:U.S. dollar amounts are translated from yen, for convenience only, at the rate of¥86.58= $1 prevailing on December 31, 2012.